Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Early research (Phase 1)Active Not RecruitingNCT05103631
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Who this might be right for
Liver Cell CarcinomaSolid TumorWilms Tumor+5 more
Baylor College of Medicine 12
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Early research (Phase 1)Ended earlyNCT04429321
What this trial is testing

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Stage IV
Abramson Cancer Center at Penn Medicine 1
Testing effectiveness (Phase 2)Ended earlyNCT00009919
What this trial is testing

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT00416871
What this trial is testing

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Centre Leon Berard 220
Testing effectiveness (Phase 2)Study completedNCT04535687
What this trial is testing

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1
Early research (Phase 1)Study completedNCT01497821
What this trial is testing

AMG 172 First in Human Study in Patients With Kidney Cancer

Who this might be right for
Renal Cell AdenocarcinomaClear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma+1 more
Amgen 37
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableStudy completedNCT02143492
What this trial is testing

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

Who this might be right for
Kidney CancerRenal Cell CarcinomaAdvanced Renal Cell Carcinoma
Argos Therapeutics 11
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Testing effectiveness (Phase 2)Study completedNCT00003914
What this trial is testing

Dolastatin 10 in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Mayo Clinic 30
Testing effectiveness (Phase 2)UnknownNCT02446795
What this trial is testing

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Consorzio Oncotech 104
Early research (Phase 1)Study completedNCT01331135
What this trial is testing

Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaAstrocytoma+13 more
Emory University 18
Early research (Phase 1)Active Not RecruitingNCT05704985
What this trial is testing

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Who this might be right for
CancerSolid TumorColorectal Cancer+6 more
DEKA Biosciences 39
Not applicableStudy completedNCT00927043
What this trial is testing

Study Evaluating Renal Cell Carcinoma Risk Factors

Who this might be right for
Carcinoma, Renal Cell
Pfizer 145
Testing effectiveness (Phase 2)Study completedNCT01517243
What this trial is testing

Phase II Study of Alternating Sunitinib and Temsirolimus

Who this might be right for
Metastatic Renal Cell Carcinoma
Dartmouth-Hitchcock Medical Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT06949215
What this trial is testing

68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision

Who this might be right for
ccRCCComplex Renal Cyst
Peking Union Medical College Hospital 70
Early research (Phase 1)Study completedNCT03502330
What this trial is testing

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Who this might be right for
Advanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Yale University 42
Testing effectiveness (Phase 2)Study completedNCT00678119
What this trial is testing

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Who this might be right for
Renal Cell Carcinoma
Argos Therapeutics 25
Next Page